Abstract
Microarray technology is expanding rapidly providing an extensive as well as promising source of data for better addressing complex questions involving biological processes. The ever increasing number and publicly available gene expression studies of human and other organisms provide strong motivation to carry out cross-study analyses. Besides, microarray technology provides several platforms to investigators that include arrays from commercial vendors like Affymetrix® (Santa Clara, CA, USA), Agilent® (Palo Alto, CA, USA), and other proprietorial arrays of various laboratories. Integration of multiple studies that are based on the same technological platform, or, combining data from different array platforms carries the potential towards higher accuracy, consistency and robust information mining. The integrated result often allows constructing a more complete and broader picture.
In this work, we highlight as well as exemplify two frameworks of microarray data integration approaches that are in practice. This follows a discussion on the important issues that may influence any microarray data integration attempt. The review, in general, intends to serve as a starting point for those interested in exploring this area of microarray study, while realizing the pertinent issues underneath.
Keywords: Data integration, issues, microarrays, microarray technology, review.
Current Bioinformatics
Title: Microarray Data Integration: Frameworks and a List of Underlying Issues
Volume: 5 Issue: 4
Author(s): Chintanu Kumar Sarmah and Sandhya Samarasinghe
Affiliation:
Keywords: Data integration, issues, microarrays, microarray technology, review.
Abstract: Microarray technology is expanding rapidly providing an extensive as well as promising source of data for better addressing complex questions involving biological processes. The ever increasing number and publicly available gene expression studies of human and other organisms provide strong motivation to carry out cross-study analyses. Besides, microarray technology provides several platforms to investigators that include arrays from commercial vendors like Affymetrix® (Santa Clara, CA, USA), Agilent® (Palo Alto, CA, USA), and other proprietorial arrays of various laboratories. Integration of multiple studies that are based on the same technological platform, or, combining data from different array platforms carries the potential towards higher accuracy, consistency and robust information mining. The integrated result often allows constructing a more complete and broader picture.
In this work, we highlight as well as exemplify two frameworks of microarray data integration approaches that are in practice. This follows a discussion on the important issues that may influence any microarray data integration attempt. The review, in general, intends to serve as a starting point for those interested in exploring this area of microarray study, while realizing the pertinent issues underneath.
Export Options
About this article
Cite this article as:
Kumar Sarmah Chintanu and Samarasinghe Sandhya, Microarray Data Integration: Frameworks and a List of Underlying Issues, Current Bioinformatics 2010; 5 (4) . https://dx.doi.org/10.2174/157489310794072517
DOI https://dx.doi.org/10.2174/157489310794072517 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
One Hundred Faces of Cyclopamine
Current Pharmaceutical Design Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial
Current Vascular Pharmacology Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools
Protein & Peptide Letters Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections
Current Drug Metabolism Sao Paulo Research Conference on Molecular Medicine and Pharmacogenetics, A Joint Meeting with the IUPHAR Sub-Committee on Pharmacogenetics and the Brazilian Pharmacogenetics Network, Sao Paulo, Brazil, September 18-20, 2008
Current Pharmacogenomics and Personalized Medicine Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology
Current Molecular Imaging (Discontinued) Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
Current Neuropharmacology Gene Therapy in Lung Transplantation
Current Gene Therapy Molecular Mechanisms of Anti-cancer Action of Garlic Compounds in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Syntetic Oligosacharides – Clinical Application in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews Heat Shock Protein 90 Inhibitors in Oncology
Current Proteomics Effect of Trichostatin A on Gelsolin Levels, Proteolysis of Amyloid Precursor Protein, and Amyloid Beta-Protein Load in the Brain of Transgenic Mouse Model of Alzheimer's Disease
Current Alzheimer Research Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
Current Drug Targets Pluripotent Stem Cell-Derived Somatic Stem Cells as Tool to Study the Role of MicroRNAs in Early Human Neural Development
Current Molecular Medicine Mechanisms of Neuronal Damage and Neuroprotection Underlying Ischemia/Reperfusion Injury after Physical Exercise
Current Drug Targets Specialisation of the Tropomyosin Composition of Actin Filaments Provides New Potential Targets for Chemotherapy
Current Cancer Drug Targets Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30
Current Topics in Medicinal Chemistry Application of Efficient Nanoparticles for Early Diagnosis and Treatment of Cancer
Current Drug Metabolism Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry